Clinical Trial Update: Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, immunogenicity, and efficacy of Cervarix HPV-16/18 vaccine in adult Japanese women; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillomavirus Infections

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 2 | Status: COMPLETED | Results posted: 2009-12-16